The largest database of trusted experimental protocols

Nimblegen seqcap ez human exome library v2

Manufactured by Illumina

The Nimblegen SeqCap EZ Human Exome Library v2.0 is a lab equipment product designed for targeted enrichment of the human exome. It provides a comprehensive solution for capturing and sequencing the protein-coding regions of the human genome.

Automatically generated - may contain errors

2 protocols using nimblegen seqcap ez human exome library v2

1

Genetic Testing for Cholestatic Liver Disease

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genetic testing for cholestatic liver disease was undertaken using targeted next‐generation sequencing (NGS), which at the time consisted of mutations in ABCB11 (adenosine triphosphate binding cassette subfamily B member 11), ABCB4, ATP8B1 (ATPase phospholipid transporting 8B1), TJP2 (tight junction protein 2), BAAT (bile acid–CoA:amino acid N‐acyltransferase), NOTCH2 (notch receptor 2), and JAG1 (jagged canonical notch ligand 1). As diagnosis was not made, whole‐exome sequencing (WES) was performed. Sequencing and bioinformatic analysis were performed at the Center for Mendelian Genomics at the University of Washington (Seattle, WA). The sample library was prepared using Roche Nimblegen SeqCap EZ Human Exome Library v2.0 (Basel, Switzerland) and sequenced on the Illumina HiSeq 2500 sequencer (San Diego, CA).
Using the Gemini software package,(10) variant effect predictor–annotated variants under an autosomal recessive model were filtered for depth greater than 6, genotype quality greater than 20, and not seen in Exome Sequencing Project 6500 (V2), 1000 Genomes (Phase 3), and Exome Aggregation Consortium (ExAC) (v.03) with minor allele frequency greater than 0.005.
+ Open protocol
+ Expand
2

Exome Sequencing and Variant Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Exome sequencing was performed using a DNA sample from at least one affected individual from each of six families (Fig. 1a, c–f, h). In family ED238, exome sequencing was carried out in five family members, including three affected siblings and their unaffected parents. Sequence capture was performed in a solution using the Roche NimbleGen SeqCap EZ Human Exome Library v2.0 to target approximately 36.6 Mb of coding regions, and sequencing was carried out using the Illumina HiSeq or NextSeq 500 platforms. FASTQ files were aligned to human reference sequence (hg19) using the Burrows-Wheeler Aligner. The Genome Analysis Toolkit (GATK) was used for realignment of regions containing indels, recalibration of base qualities, and variant detection and calling,6 (link) and variants were annotated using SeattleSeq137. Apparent novel homozygous variants were checked in public databases including dbSNP, 1000 Genomes, and Exome Variant Server (EVS), and in sequences of 400 normal individuals from the same ethnic groups. The FERMT1, FLG, and KRT14 genes were Sanger-sequenced as candidates in affected members of ED113, ED156, and ED236, respectively. Cosegregation of apparent pathogenic variants was tested by Sanger sequencing using DNA samples from the rest of the family members.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!